Top scientists lay out sweeping recommendations for ‘moonshot’ against cancer

Where is the sweeping recommendations for the stroke moonshot? We have none but we do have fucking failures of stroke associations to comfort us instead.
Mine are here:
Address the complete problems in stroke.
 And here:
These 177 hyperacute therapies that need more research.
And here:
My 31 ideas on hyperacute therapy I'm going to insist my doctor give me during the first week.
And here: 
To test out these 17 diagnosis possibilities to find out which one is the best? Or maybe the Qualcomm Xprize for the tricorder? 
And here: 
Solve the neuronal cascade of death by these 5 causes in the first week. 
https://www.statnews.com/2016/09/07/cancer-research-moonshot-panel-report/
A panel of top scientists is urging the Obama administration to bet big on tumor profiling and immunotherapy treatments in its cancer moonshot — two areas that are viewed with great promise, but still face unanswered questions about their ultimate effectiveness.

The experts are recommending the creation of a new national network that would allow cancer patients across the country to have their tumors genetically profiled and included in a new national database — one of several recommended steps that they say would significantly speed the progress of cancer research in the United States.

The panel is also urging the creation of a network to coordinate clinical trials using immunotherapy, the promising new treatment that turns the body’s immune system against the disease.

article continues after advertisement

Sponsor Content

The physician-scientist: Travis Hinson’s journey to a better heart

Mixing numerous chemicals just wasn’t enough for Travis Hinson. “I wanted to do science that made a difference in people’s health.” For Hinson, that difference is with the heart.

Sponsor Content by The Jackson Laboratory

The recommendations are part of a report issued Wednesday by an expert panel advising the White House in its cancer moonshot initiative. It was formally accepted by the National Cancer Advisory Board Wednesday morning.

The tumor network would help scientists better identify which treatments work for which cancers in which patients, the panel said. As scientists become more aware of the many different kinds of cancer, and turn increasingly to more personalized treatments, they see the profiling the genetics of individual tumors as crucial.

Patients would be connected with the hospitals and cohorts across the country that profile tumors and those institutions would share the collected data. The network would both aid in enrolling specific patients in clinical trials that show promise for their cancer by letting them “pre-register” for trials, the panel said, and allow researchers to make broader observations about the genetic makeup of different cancers and about which treatments are successful in fighting them.